Over the last several years, the opioid crisis has become a household discussion as government agencies have increased efforts to build awareness of and prevent further deaths from controlled substance abuse. As part of…
Continue Reading
When the Drug Enforcement Administration (DEA) released its proposed rule that would remove some of the Covid-19 telehealth flexibilities for the prescribing of controlled substances, it caused an uproar from telehealth companies and advocates….
Continue Reading
By Anuja Vaidya
November 06, 2023 – A bipartisan group of four senators reintroduced legislation that would eliminate barriers to the virtual prescription of medication for opioid use disorder (OUD).
Called the Telehealth Response for E-prescribing Addiction…
Continue Reading
The DEA has extended remote prescribing of controlled substances until the end of 2024, granting a second extension to consider new regulations. This move eliminates the proposed rule requiring in-person visits for controlled medication…
Continue Reading
At the Drug Enforcement Agency Drug Diversion Division listening sessions earlier this month, DEA Administrator Anne Milgram said the agency would hold a second comment period on its March NPRM in the months ahead.WHY…
Continue Reading
This is a developing story with updates expected.U.S. Senators Mark Warner (D-Va.), John Thune (R-S.D.) and four of their colleagues expressed support for the Drug Enforcement Administration’s new engagement on a potential special registration…
Continue Reading
As the Drug Enforcement Administration (DEA) holds listening sessions this week for its proposed rule that rolls back Covid-19 flexibilities for the virtual prescribing of controlled substances, four mental health companies issued a letter…
Continue Reading
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s…
Continue Reading
The DEA’s potential introduction of a telehealth-controlled substance registry is lauded by the American Telemedicine Association (ATA). The DEA’s upcoming listening sessions aim to explore the feasibility of remote prescribing of essential controlled substances…
Continue Reading
The American Telemedicine Association released a statement on Friday saying that it applauds the Drug Enforcement Agency for posting a meeting notice on Friday that indicates that it is “openly considering” a special registration that would…
Continue Reading
